Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: wong ty. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Pilot and feasibility studies in ophthalmology: fundamental keys to success.
Nanji K, Phillips M, Thabane L, Tham YC, Wong TY, Steel DH, Munk MR, Wykoff CC, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Nanji K, et al. Among authors: wong ty. Eye (Lond). 2024 Nov 21. doi: 10.1038/s41433-024-03413-6. Online ahead of print. Eye (Lond). 2024. PMID: 39572846 No abstract available.
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff.
Ziemssen F, Sylvanowicz M, Amoaku WM, Aslam T, Eldem B, Finger RP, Gale RP, Kodjikian L, Korobelnik JF, Lin X, Loewenstein A, Mitchell P, Murphy M, Owens DR, Parker N, Pearce I, Rodríguez FJ, Stern J, Talks SJ, Wong DT, Wong TY, Barratt J. Ziemssen F, et al. Among authors: wong ty. Ophthalmol Ther. 2024 Dec 14. doi: 10.1007/s40123-024-01060-4. Online ahead of print. Ophthalmol Ther. 2024. PMID: 39673039
Causes of vision loss worldwide, 1990-2010: a systematic analysis.
Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR; Vision Loss Expert Group. Bourne RR, et al. Lancet Glob Health. 2013 Dec;1(6):e339-49. doi: 10.1016/S2214-109X(13)70113-X. Epub 2013 Nov 11. Lancet Glob Health. 2013. PMID: 25104599 Free article. Review.
Risk assessment models: considerations prior to use in clinical practice.
Darzi AJ, Busse JW, Torabiardakani K, Phillips M, Thabane L, Bhandari M, Borrelli E, Steel DH, Wykoff CC, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Darzi AJ, et al. Eye (Lond). 2024 Dec 18. doi: 10.1038/s41433-024-03557-5. Online ahead of print. Eye (Lond). 2024. PMID: 39695254 No abstract available.
2,282 results